Meta-Analysis: The Effect of Statins on Albuminuria

Figure 2. Residual statistical heterogeneity: I   = 23% (   = 0.27) for excretion < 30 mg/d; I   = 0% (   = 0.64) for excretion of 30 to 299 mg/d; and I   = 63% (   = 0.020) for excretion ≥ 300 mg/d. WMD = weighted mean difference in the proportional change from baseline to follow-up albuminuria (or proteinuria) between statin and placebo groups.
Figure 2. Residual statistical heterogeneity: I   = 23% (   = 0.27) for excretion < 30 mg/d; I   = 0% (   = 0.64) for excretion of 30 to 299 mg/d; and I   = 63% (   = 0.020) for excretion ≥ 300 mg/d. WMD = weighted mean difference in the proportional change from baseline to follow-up albuminuria (or proteinuria) between statin and placebo groups. Individual and pooled results of 15 randomized, placebo-controlled trials examining the effect of statins on albuminuria or proteinuria, stratified by baseline excretion.2P2P2P

This Article

  1. Ann Intern Med July 18, 2006 vol. 145 no. 2 117-124
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. November 17, 2009, 151 (10)
  1. Alert me to current issues